Acute kidney injury in hematological patients treated with CAR-T cells: risk factors, clinical presentation and impact on outcomes

Abstract Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of hematologic malignancies, yet it carries significant risks, including acute kidney injury (AKI). In this study, we investigated the risk factors and clinical impact of AKI in patients undergoing CAR-T cell...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Elisa Russo, Massimiliano Gambella, Anna Maria Raiola, Elena Beltrametti, Valentina Zanetti, Giuseppe Chirco, Francesca Viazzi, Emanuele Angelucci, Pasquale Esposito
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Nature Portfolio 2024-11-01
Sarja:	Scientific Reports
Aiheet:	Acute kidney injury Performance status CAR-T cell therapy Cytokine release syndrome Disease-free survival Mortality
Linkit:	https://doi.org/10.1038/s41598-024-77720-z
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!